Yasuo Mori

5.1k total citations · 1 hit paper
102 papers, 2.9k citations indexed

About

Yasuo Mori is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Yasuo Mori has authored 102 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 23 papers in Immunology and 21 papers in Oncology. Recurrent topics in Yasuo Mori's work include Hematopoietic Stem Cell Transplantation (25 papers), Immune Cell Function and Interaction (14 papers) and Acute Myeloid Leukemia Research (12 papers). Yasuo Mori is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Immune Cell Function and Interaction (14 papers) and Acute Myeloid Leukemia Research (12 papers). Yasuo Mori collaborates with scholars based in Japan, United States and Norway. Yasuo Mori's co-authors include Koichi Akashi, Hiromi Iwasaki, Toshihiro Miyamoto, Katsuto Takenaka, Irving L. Weissman, Jun Seita, Yoshikane Kikushige, Goichi Yoshimoto, Rahul Sinha and Hiroaki Niiro and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yasuo Mori

85 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A molecular cell atlas of the human lung from single-cell RNA sequencing

2020 840 citations Kyle J. Travaglini, Ahmad N. Nabhan et al. Nature profile →

Peers

Countries citing papers authored by Yasuo Mori

Since Specialization

Citations

This map shows the geographic impact of Yasuo Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Mori more than expected).

Fields of papers citing papers by Yasuo Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Mori. The network helps show where Yasuo Mori may publish in the future.

Co-authorship network of co-authors of Yasuo Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Mori. A scholar is included among the top collaborators of Yasuo Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Mori. Yasuo Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study 2025 ·International Journal of Hematology ·Tatsunori Goto, Hiroshi Okamura, Takashi Ikeda, Yasuo Mori, Souichi Shiratori, Shin‐ichiro Fujiwara, (unknown), Ken‐ichi Matsuoka, Yuta Katayama, Yi‐Bin Chen, Yngvar Fløisand, Guillermo Rossiter, Johan Jansson, (unknown), Takanori Teshima	1
2	TRPC6-Mediated Zn2+ Influx Negatively Regulates Contractile Differentiation of Vascular Smooth Muscle Cells 2025 ·Biomolecules ·(unknown), (unknown), T. Ito, Yuri Kato, Akiyuki Nishimura, Ryu Nagata, Yasuo Mori, Motohiro Nishida	0
3	HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis 2024 ·International Journal of Hematology ·Keiko Fukunaga, Kazuhiro Ikegame, Hirohisa Nakamae, Noriko Doki, Takahiro Fukuda, Yukio Kondo, Takahide Ara, Tetsuya Eto, Yasuo Mori, Ken‐ichi Matsuoka, Yoshinobu Kanda, Makoto Onizuka, Yoshiko Atsuta, Tatsuo Ichinohe, Satoko Morishima, Junya Kanda, (unknown)	0
4	A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells 2024 ·PubMed ·(unknown), Noriaki Kawano, Yasuo Mori, Takuji Yamauchi, (unknown), Kohta Miyawaki, (unknown), (unknown), (unknown), Kiyoshi Yamashita, (unknown), Ikuo Kikuchi, Kousuke Marutsuka, Koichi Ohshima, Koji Kato, Koichi Akashi	1
5	Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma 2024 ·Cancer Science ·Yasuo Mori, Jun Takizawa, (unknown), Naoki Takezako, Koji Nagafuji, Hiroshi Handa, Junya Kuroda, Kazutaka Sunami, Tomohiko Kamimura, Ryosuke Ogawa, Yoshikane Kikushige, Mine Harada, Koichi Akashi, Toshihiro Miyamoto, (unknown)	1
6	Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation 2024 ·Bone Marrow Transplantation ·Takeshi Sugio, Naoyuki Uchida, Kohta Miyawaki, Yuju Ohno, Tetsuya Eto, Yasuo Mori, Goichi Yoshimoto, Yoshikane Kikushige, Yuya Kunisaki, Shinichi Mizuno, Koji Nagafuji, Hiromi Iwasaki, Tomohiko Kamimura, Ryosuke Ogawa, Toshihiro Miyamoto, Shuichi Taniguchi, Koichi Akashi, Koji Kato	0
7	Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma 2024 ·Bone Marrow Transplantation ·(unknown), Hirohisa Nakamae, (unknown), Eisei Kondo, Takahiro Fukuda, Nobuhiro Hiramoto, Yasuo Mori, Koji Nagafuji, Tetsuya Eto, Yasushi Onishi, Naoyuki Uchida, Jun Ishikawa, Ken‐ichi Matsuoka, Shunsuke Yui, Ken Takase, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako	1
8	TIM‐3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation 2024 ·Cancer Science ·(unknown), Yoshikane Kikushige, (unknown), (unknown), (unknown), Yuichiro Semba, (unknown), Takahiro Shima, Yasuo Mori, (unknown), Tomohiko Kamimura, Hiromi Iwasaki, Ryosuke Ogawa, (unknown), Koji Kato, Takahiro Maeda, Toshihiro Miyamoto, (unknown)	0
9	Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation 2024 ·British Journal of Haematology ·(unknown), Yoshimitsu Shimomura, Sung‐Won Kim, Hiroyuki Ohigashi, Jun Ishikawa, (unknown), Nobuhiro Hiramoto, Ishikazu Mizuno, (unknown), Yasunori Ueda, Ken‐ichi Matsuoka, Kimikazu Yakushijin, Yasuo Mori, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Shinichi Kako	1
10	Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy 2023 ·Blood ·(unknown), Yoshimitsu Shimomura, Takayoshi Tachibana, Yuho Najima, Jun Aoki, Yu Akahoshi, Masatsugu Tanaka, Noriko Doki, Naoyuki Uchida, Hiroyuki Ohigashi, Hikaru Kobayashi, Shuichi Ota, Miho Nara, Shin‐ichiro Fujiwara, Yasuo Mori, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai	0
11	Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020 2023 ·Medical Mycology ·(unknown), Yoshihiro Eriguchi, Noriko Miyake, Yoji Nagasaki, Akiko Yonekawa, Yasuo Mori, Koji Kato, Koichi Akashi, Nobuyuki Shimono	4
12	Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide 2023 ·Bone Marrow Transplantation ·Yoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, (unknown), Yu Akahoshi, Junya Kanda, Hiroyuki Ohigashi, Hirohisa Nakamae, Nobuhiro Hiramoto, Koji Nagafuji, Takashi Tanaka, Tetsuya Eto, Shuichi Ota, Yumiko Maruyama, Takashi Akasaka, Ken‐ichi Matsuoka, Yasuo Mori, Takahiro Fukuda, Yoshiko Atsuta, Seitaro Terakura	2
13	Clinical and prognostic features of Langerhans cell histiocytosis in adults 2023 ·Cancer Science ·Aki Sato, Masayuki Kobayashi, (unknown), Miho Ogawa, Eigo Shimizu, Toyotaka Kawamata, Kazuaki Yokoyama, Yasunori Ota, Tatsuo Ichinohe, Hitoshi Ohno, Yasuo Mori, Emiko Sakaida, Tadakazu Kondo, Seiya Imoto, Yasuhito Nannya, Kinuko Mitani, Arinobu Tojo	7
14	A molecular cell atlas of the human lung from single-cell RNA sequencing breakdown → 2020 ·Nature ·Kyle J. Travaglini, Ahmad N. Nabhan, Lolita Penland, Rahul Sinha, Astrid Gillich, Rene Sit, Stephen Chang, Stephanie D. Conley, Yasuo Mori, Jun Seita, Gerald J. Berry, Joseph B. Shrager, Ross J. Metzger, Christin S. Kuo, Norma Neff, Irving L. Weissman, Stephen R. Quake, Mark A. Krasnow	840
15	Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation 2020 ·PLoS Pathogens ·(unknown), Toru Takeshita, (unknown), Shinya Kageyama, Mikari Asakawa, Yasuo Mori, Toshihiro Miyamoto, Jun Hata, Toshiharu Ninomiya, Haruhiko Kashiwazaki, Yoshihisa Yamashita	19
16	Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma 2019 ·Molecular Cancer Therapeutics ·Tatsushi Kodama, (unknown), (unknown), Hideaki Mizuno, Takeshi Baba, Kiyoshi Habu, Noriaki Sawada, Hiroyuki Tsunoda, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Yasuo Mori, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi	62
17	[Ruxolitinib for treatment of GvHD in patients with myelofibrosis]. 2019 ·PubMed ·Yasuo Mori	0
18	Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting 2018 ·Journal of Pharmaceutical Health Care and Sciences ·Mayako Uchida, Tsutomu Nakamura, Kojiro Hata, Hiroyuki Watanabe, Yasuo Mori, Koji Kato, Kenjiro Kamezaki, Katsuto Takenaka, Motoaki Shiratsuchi, Keiko Hosohata, Toshihiro Miyamoto, Koichi Akashi	8
19	FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD–specific STAT5 activation 2009 ·Blood ·Goichi Yoshimoto, Toshihiro Miyamoto, Siamak Jabbarzadeh‐Tabrizi, Tadafumi Iino, Jennifer L. Rocnik, Yoshikane Kikushige, Yasuo Mori, Takahiro Shima, Hiromi Iwasaki, Katsuto Takenaka, Koji Nagafuji, Shin-ichi Mizuno, Hiroaki Niiro, Gary Gilliland, Koichi Akashi	200
20	Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation 2009 ·International Journal of Hematology ·Yasuo Mori, Takatoshi Aoki, Katsuto Takenaka, Takuji Yamauchi, (unknown), Kenjiro Kamezaki, Hiromi Iwasaki, Naoki Harada, Toshihiro Miyamoto, Koji Nagafuji, Takanori Teshima, Koichi Akashi	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact